comparemela.com

Brain Care Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Drug May Help Slow Effects of Alzheimer s for Those with Mild Symptoms | University of Utah Health

To date, lecanemab is the first traditional approval of a treatment for Alzheimer’s disease. Lecanemab holds promise for patients in early stages of the disease.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.